IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,398 | -20.9% | 249,047 | -12.3% | 0.01% | -14.3% |
| Q2 2023 | $3,032 | -5.6% | 284,051 | -6.9% | 0.01% | -12.5% |
| Q1 2023 | $3,212 | +74.6% | 305,008 | +105.7% | 0.01% | +60.0% |
| Q4 2022 | $1,840 | -99.9% | 148,257 | -4.4% | 0.01% | 0.0% |
| Q3 2022 | $1,605,000 | -9.1% | 155,068 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $1,765,000 | +1549.5% | 152,945 | +1811.8% | 0.01% | – |
| Q1 2022 | $107,000 | +15.1% | 8,000 | 0.0% | 0.00% | – |
| Q4 2021 | $93,000 | -82.2% | 8,000 | -79.9% | 0.00% | -100.0% |
| Q3 2021 | $523,000 | +407.8% | 39,773 | +397.2% | 0.00% | – |
| Q2 2021 | $103,000 | -9.6% | 8,000 | -22.1% | 0.00% | – |
| Q1 2021 | $114,000 | -2.6% | 10,270 | 0.0% | 0.00% | – |
| Q4 2020 | $117,000 | +27.2% | 10,270 | 0.0% | 0.00% | – |
| Q3 2020 | $92,000 | -12.4% | 10,270 | 0.0% | 0.00% | – |
| Q2 2020 | $105,000 | -23.9% | 10,270 | -24.6% | 0.00% | – |
| Q1 2020 | $138,000 | -23.3% | 13,624 | 0.0% | 0.00% | – |
| Q4 2019 | $180,000 | -16.7% | 13,624 | -31.2% | 0.00% | – |
| Q2 2019 | $216,000 | -19.1% | 19,792 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $267,000 | +80.4% | 19,792 | +33.4% | 0.00% | – |
| Q4 2018 | $148,000 | -46.0% | 14,842 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $274,000 | -3.5% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $284,000 | +24.0% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $229,000 | +3.2% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $222,000 | -5.5% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $235,000 | -16.1% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $280,000 | +10.7% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $253,000 | +11.0% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $228,000 | -51.5% | 14,842 | -50.0% | 0.00% | 0.0% |
| Q3 2016 | $470,000 | +143.5% | 29,684 | +100.0% | 0.00% | 0.0% |
| Q2 2016 | $193,000 | +19.1% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $162,000 | -5.8% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $172,000 | +11.0% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $155,000 | -12.9% | 14,842 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $178,000 | +42.4% | 14,842 | +89.3% | 0.00% | – |
| Q1 2015 | $125,000 | +4.2% | 7,842 | 0.0% | 0.00% | – |
| Q4 2014 | $120,000 | +17.6% | 7,842 | 0.0% | 0.00% | – |
| Q3 2014 | $102,000 | -15.0% | 7,842 | 0.0% | 0.00% | – |
| Q2 2014 | $120,000 | +25.0% | 7,842 | 0.0% | 0.00% | – |
| Q1 2014 | $96,000 | +5.5% | 7,842 | 0.0% | 0.00% | – |
| Q4 2013 | $91,000 | – | 7,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |